MORAN SEAN F. (Chief Financial Officer) received a stock award from CORBUS PHARMACEUTICALS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2025ACC: 0000950170-25-013702
Officer· Chief Financial Officer
Since Jan 2019
+120K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
120K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+27.50K
Price / share
—
Trade value
—
% of position
56.6%
1/31/2025
48.60K→76.11K
Total
Net shares
+27.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 1/31/2025 | A · Award | +27.50K | — | — | 56.6% | 48.60K | 76.11K |
| Total | +27.50K | $0.00 | ||||||
Derivative Transactions1
Stock options (right to buy)
Direct
Converts to
Common Stock
92.50K shares
Shares
+92.50K
Strike price
9.79
Held after
92.50K
Exercisable
—
1/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock options (right to buy) Direct | Common Stock92.50K shares | 1/31/2025 | A · Award | +92.50K | 9.79 | — | 92.50K |